The data describes the number of pharmaceutical industry violations in the United States from 1991 to 2015, by the type of violation. Over this time there were ten reported violations of poor manufacturing practices in which pharmaceutical companies sold drug products that failed to meet Food and Drug Administration (FDA) standards and specifications.
Overcharging government health programs | 201 |
Unlawful promotion | 105 |
Kickbacks | 47 |
Monopoly practices | 25 |
Concealing data | 16 |
Poor manufacturing practices | 10 |
Environmental violations | 10 |
Financial violations | 4 |
Illegal distribution | 4 |